Skip to content

Clinical trials

Phase 2/3 Ovarian Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 2/3 Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20064
20111
20141
20161
20171
20181
20191
20211
20234
20243
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting9
Completed6
Active, not recruiting3
Terminated3
Unknown status3
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cancer Research UK3
National Cancer Institute (NCI)2
Pierian Biosciences2
AB Science1
Blokhin's Russian Cancer Research Center1
Daiichi Sankyo1
GE Healthcare1
Gynaecologisch Oncologisch Centrum Zuid1
Ludwig-Maximilians - University of Munich1
Menarini Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms26
Fallopian Tube Neoplasms9
Carcinoma, Ovarian Epithelial4
Colorectal Neoplasms4
Lung Neoplasms4
Hematologic Neoplasms3
Neoplasms3
Pancreatic Neoplasms3
Breast Neoplasms2
Carcinoma, Non-Small-Cell Lung2

Trials

Showing 26 to 26 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.